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The sequenced human genome potentially offers a
wealth of useful knowledge to researchers. The
better part of this promise, however, is conditioned
by the availability of this information in a form
accessible to computational methodologies. Repre-
sentations such as IUPAC
1, and formats such as
FASTA have made it possible to develop and apply
bioinformatics tools to genomic data. Collections
of analytical tools developed so far assume that
information is represented in a standard way,
thereby greatly increasing the reusability of code,
and reducing the time necessary for the develop-
ment of new methods. While genomics research has
had much to gain from this common structure, the
fact that some essential standards are still lacking is
an impediment to the commercialization of new
bioinformatics tools.
A reiteration of this effort is much needed for the
post-genomics age, but the task required goes far
beyond analyzing sequences and molecular struc-
tures. The challenge now facing researchers is to
represent, analyze, and model molecular interac-
tions and biochemical systems, in an integrative
approach commonly known as systems biology [3],
in order to determine how groups of proteins
function within the context of a cell. These are
very new areas for life sciences informatics,
demanding novel representations and correspond-
ing algorithms. Similar – albeit arguably simpler –
modeling problems have been encountered in other
phenomenological ﬁelds, however, such as engineer-
ing or telecommunications, and theoretical tools
have been developed to tackle them. Some of these
tools can be adapted to the context of systems
biology, and can help in turn organize the scientiﬁc
effort toward a coherent understanding of biologi-
cal mechanisms. The BioPathways Consortium [1]
has a dual mission: to propose and advance the
post-genomic informatics to this next level of
scientiﬁc research, and to help the industry adopt
practical guidelines and standards. We present
below some of BPC’s activities since its formation
in June 2000, and offer a vision of how our efforts
will support systems biology research.
Data formats for DNA and protein sequences
have been developed over the last 30 years, and are
usually based on binary or string representations,
such as IUPAC. While sequence representations have
been standardized, other associated components of
information, such as functional descriptions, are not.
Recently, the GeneOntology consortium (http://
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into a taxonomy. This effort has resulted in a
controlled vocabulary, common to several genomes,
that can be incorporated into annotations. Yet a
more complete language of descriptors is still
needed to describe how proteins and genes interact
and associate with each other.
Life sciences research has now entered the ‘post-
genomics age’, where the focus is moving from
isolated molecular structures to systems of interact-
ing molecules. Representations for transcriptomic
and proteomic data are actively becoming standard-
ized (MAGE-OM, I3C) to handle the onslaught of
data from newly emerging high-throughput tech-
nologies, such as chip arrays and mass spectro-
meters. Yet the capture of a formal interpretation
of this data also requires a descriptive language.
Scientists are now faced with the challenge of
having to denote biochemical processes and dy-
namic behavior using formal models. These models
are often based on graphs, mathematical entities
composed of sets of vertices connected by edges [2].
Graphs may be used to represent causal ﬂow
(directed) in biochemical processes, or to describe
non-directional molecular interactions and associa-
tions (undirected) between two or more molecules.
Graph theory is a fairly mature sub-ﬁeld of discrete
mathematics and theoretical computer science:
graphs, as mathematical objects, are well under-
stood. For instance, it is well known that certain
kinds of graph problems are computationally
intractable. To illustrate how fast graphs can grow
in complexity, consider a 4-node labeled graph,
which has 2
4r4) 65536 possible directed edge
combinations, while a 10-node graph has 1.27r
10
30 combinations. Clearly a simple bio-molecular
system represented as a graph could overwhelm
even the most powerful supercomputers today. If
one assumes the human genome encodes 100 000
proteins, the total number of 2-way interactions
possible between all proteins is about 10
30,103!I n
other words, how we represent biological systems
and the computational techniques we use to analyze
them will have a strong bearing on how well we can
elucidate and model such systems.
The term pathway is often used to describe
biochemical systems. It is, however, fraught with
multiple connotations that many researchers believe
are misleading. Many assume that it interjects a linear
model of biochemical events, while others interpret it
as more general, including such forms as directed
acyclic graphs [2]. Several researchers have suggested
using the alternative terms ‘network’ or ‘circuitry’.
Yet it seems that many have grown accustomed to the
term pathways to mean a consequential system of
interactions, even though feedback loops may be part
of such a system. The BioPathways Consortium has
advocated the use of this term in its name for this
reason, but stresses that it has a much larger
interpretation to be as inclusive as possible.
A characterization for some of the categories of
pathway information is now in order. metabolic
pathways, such as those found on the classical
Boehringer-Mannheim chart, illustrate how sub-
strates are catalytically altered by enzymes to pro-
duce products along a path of biochemical reactions
[4]. Signal transduction pathways involve cascades of
molecular interactions and activations, which are
used to transmit and amplify signals relevant to the
cell [8]. Gene regulatory networks, forming the last
category, represent the circuitry by which gene ex-
pression activation spreads to downstream genes,
affecting their expression. In actuality, a gene is
regulated by the interaction between active tran-
scriptional factors in the nucleus and the sequences
surrounding a gene known as cis-elements. These
models describe logic circuits on how genes control
each other, and subsequently the cellular states [3].
They can be construed as abstract views of net-
works of actual physical interactions.
A related category is that of protein interaction
maps, describing networks of physical interactions
between proteins or protein domains. One way to
interpret these maps is to see them as partial and
incomplete descriptions of pathways: although the
exact nature, causal ﬂow, separation into indepen-
dent pathways or temporal sequence of interactions
are unknown, the template of the pathways net-
works is present. Recent technological progress has
raised the throughput and reliability of experimen-
tal techniques (typically based on yeast-2-hybrid
assays) to a level potentially compatible with large-
scale pathway reconstruction [9,7,6].
Pathway data is contained within databases,
whose schemas reﬂect the kind of pathway category
model they describe. Many databases already exist
that represent and store various kinds of pathways
and molecular interactions information. Some of
the most established are KEGG, EcoCyc, BRENDA,
WIT2 for Metabolic Pathways, CSNDB, AFCS,
SPAD, BRITE and TransPath for Signaling Path-
ways, TRRD or TransPath for Gene Regulatory
Networks, BIND, DIP, MIPS and GeneNet for
protein interactions [1]. Some of these databases
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relational, while others are object-oriented or
represent information using more complex data-
structures or knowledge-representation techniques.
Whatever the underlying storage and query engine
type and its associated expressiveness, however,
each database relies on a speciﬁc data model to
structure its information.
A question asked by many scientists is whether it
is at all possible to ‘unite’ all these models together
into one schema. A uniﬁed database would in parti-
cular allow researchers to query multiple kinds of
pathway information that may be associated, yet
involve different types of pathways, for instance
gene networks to regulate house-keeping metabolic
enzymes. Such a view would greatly help in under-
standing what the downstream metabolic effects
are, beginning from the gene regulation level.
One reason such direct uniﬁcation appears difﬁ-
cult, however, is that the schemas for each category
have been designed by separate scientiﬁc commu-
nities, to represent different biological phenomena
with speciﬁc biases: metabolic pathways focus on
step-by-step processing of biochemical products
through catalysis, dividing the entities into mutable
substrates and immutable enzymes. Classical repre-
sentations of signal cascades [8] involve the serial
activation (deactivation) of proteins that themselves
may be activators (deactivators), so that they are
simultaneously both operators and operands. More-
over, not only are many existing data models
speciﬁc to a type of pathways, but most have been
designed with speciﬁc applications in mind, such as
pathway reconstruction, simulation, or annotation.
Because of this unavoidable dependency between
model and purpose, the idea of a unique ‘one-size
ﬁts all’ pathways model at the detailed ‘relational
schema’ level may be unattainable.
At a higher level of abstraction, however, the
most expressive ‘common denominator’ elements
tend to emerge from practice; for instance, distinc-
tion between catalytic activities and enzymes is a
necessity if one is to represent multiple catalytic
inﬂuences on reactions. Ontologies are a way to
describe in a formal and structured way such con-
ceptual bricks and their interrelations; for example,
the kinds of relationships between biochemical
molecules such as allosteric modulation, competitive
inhibition, covalent activation, non-covalent binding,
catalysis, associative anchoring, complex stabiliza-
tion, transcriptional binding, or receptor coupling.
While the exact deﬁnition and scope of the word
‘ontology’ is still a subject of heated debate within the
community, many researchers strongly feel the
necessity of some kind of higher-level structured
representation of pathway information [5], to allow
for deeper analyses and functional inferences.
One of the foundational and ongoing activities of
the BioPathways Consortium is to identify and
categorize applications of computational represen-
tations of pathways information, assess the require-
ments these applications impose on data models,
and assess the adequacy of existing formalisms –
such as Petri Nets, process algebra (e.g., pi-calculus,
ambient-calculus), and partial differential equations
[4] – to the description of the various model classes.
Another major area of activity of the Consortium is
promoting the identiﬁcation and speciﬁcation of a
set of commonly accepted ontologies that can work
together with the above formalisms.
Standards for representing pathway information
would indeed be beneﬁcial to the development of
pathway algorithms and tools. While the different
application types that utilize pathway data in one
form or another induce different requirements on
the underlying models, many projects rely on the
interplay between several applications, clearly
underlining the need for a common data (and
knowledge) interchange model. There will certainly
be many more advanced applications developed in
the near future, and the ease with which these can
be realized will depend strongly on how much can
be deﬁned as a core set of guidelines and formalisms
for pathways informatics.
Organizations exist that can help promote any
such speciﬁcations and standards, including I3C
(http://www.i3c.org), LSR-OMG (http://www.omg.
org/lsr), and the Bio-Ontologies Consortium. Life
science informaticists are also increasingly relying
on the ease and expressiveness of XML-based ex-
change formats. Recently, the World-Wide-Web
Consortium, which has deﬁned and promoted
XML standards, has also been working on the
description of semantics for the content of XML
documents called DAML (DARPA Agent Markup
Language). This may offer a promising approach to
organizing the complex data that can be associated
with biological systems.
Within that context, the Biopathways Consor-
tium aims at fostering the development of pathways
informatics by a variety of means:
$ synthesis and dissemination of scientiﬁc informa-
tion on this emerging ﬁeld, often from distant or
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$ identiﬁcation of scientiﬁc and IT challenges
$ issuance of recommendations on standards
$ support of industry-academia collaborations
$ coordination with other life sciences groups
Several concurrent activities are currently being
pursued by the Biopathways Consortium work-
groups:
1. Formalisms: assessment of existing formalisms,
data models, and exchange models, as well as
recommendations on ontologies
2. Visualizations: identiﬁcation and classiﬁcation of
tools and approaches
3. Database integration: the proposed PARIS pro-
ject aiming at the design, development and
maintenance of a public pathways information
database
4. Pathway reconstruction: assessment and advance-
ment of the algorithms for pathways information
reconstruction from possibly heterogeneous
sources of experimental data, as well as assess-
ment of the nature, quality and quantity of the
experimental data required.
5. Text mining from scientiﬁc literature: assess-
ment, transfer and development of tools and
techniques; an award received recently from Sun
will allow the consortium to develop a test-bed
for community research projects.
More information can be found on the Bio-
Pathways Consortium web site: http://www.
biopathways.org
Even though this ﬁeld is still nascent, there are
pressing issues already that BioPathways can help
address. A major driver is the need to interpret and
organize newly produced genomic and proteomic
data in the context of pathways and complex causal
mechanisms. This data occurs in the form of micro-
array data, mass spectrograms, metabolite proﬁles,
and protein interaction networks. Model systems
for analyzing this data and organizing it as suppor-
tive evidence for pathways and incorporation are
urgently required. Speciﬁcally, gene expression
research is increasingly being used to investigate
the underlying network of mechanisms that regulate
genes and may be the cause of many diseases. As
new high-throughput technologies start producing
new kinds of biological molecular data, these too
must be consolidated into pathway models.
Pathways informatics is an interdisciplinary sub-
ject, involving rich modeling problems as well as
difﬁcult IT challenges. It is fueled mostly by the
availability of information of such nature and
quantity that exchange is an absolute necessity,
and pulled by a variety of applications whose
common points and key underlying concepts have
not yet been clearly identiﬁed. Yet fruitful dialogue
between biologists and computer scientists is an
order of magnitude more important in dealing with
pathways information than it was for sequence
information, and will require the application of
several of the above core concepts. Pathways
informatics is a key enabler for the systems biology
approach mentioned above. It is our hope that the
Biopathways Consortium can be an enabler for
pathways informatics.
Acknowledgement
Our ﬁrst thanks go to all active institutional or individual
participants in BioPathways Consortium activities, a list
unfortunately too long to reproduce here. We are especially
indebted to Aviv Regev and Joanne Luciano, for many
fruitful discussions on the ﬁeld of pathways informatics, and
for their help in organizing Consortium efforts.
Finally, the authors and Consortium co-founders wish to
thank their institutions, Beyond Genomics and Hybrigenics,
for their unfailing support, as well as Pierre Legrain and
Donny Strosberg for a critical reading of the manuscript.
References
1. Biopathways Consortium: http://www.biopathways.org
2. Bollobas B. 1998. Modern Graph Theory. Springer-Verlag:
New York.
3. Ideker T, Thorsson V, Ranish JA, et al. 2001. Integrated
genomic and proteomic analyses of a systematically perturbed
metabolic network. Science 292: 929–934.
4. Jamshidi N, Edwards JS, Church GM, Palsson BO. 2000. A
computer model of human red blood cell metabolism.
Bioinformatics 17: 286–287.
5. Karp PD. 2001. Pathway databases: a case study in computa-
tional symbolic theories. Science 293: 2040–2044.
6. Legrain P, Jestin JL, Scha ¨chter V. 2000. From the analysis of
protein complexes to proteome-wide linkage maps. Curr Opin
Biotechnol 11: 402–407.
7. Rain JC, Selig L, De Reuse H, et al. 2001. The protein–
protein interaction map of Helicobacter pylori. Nature 409:
211–215.
8. Roberts CJ, Nelson B, Marton MJ, et al. 2000. Signaling and
circuitry of multiple MAPK pathways revealed by a matrix of
global gene expression proﬁles. Science 287: 873–880.
9. Uetz P, Giot L, Cagney G, et al. 2000. A comprehensive
analysis of protein-protein interactions in Saccharomyces
cerevisiae. Nature 403: 623–627.
118 E. K. Neumann and V. Schachter
Copyright # 2002 John Wiley & Sons, Ltd. Comp Funct Genom 2002; 3: 115–118.